What it's for (Indications)
- Polymyxin B + Neomycin + Hydrocortisone otic solution is indicated for the treatment of superficial bacterial infections of the external auditory canal (acute diffuse external otitis or 'swimmer's ear') caused by organisms susceptible to the antibiotics polymyxin B and neomycin.
- The hydrocortisone component acts as an anti-inflammatory, antipruritic, and vasoconstrictive agent, providing symptomatic relief from the associated inflammation, itching, and swelling.
- This combination is particularly useful when inflammation is a prominent feature of the otitis externa, aiming to reduce discomfort while combating the bacterial pathogen.
- Its use should be restricted to infections where susceptibility of the causative organisms has been established or is highly suspected.
- This comprehensive approach targets both the infectious agent and the inflammatory response, enhancing patient comfort and recovery.
- The product is not intended for deep-seated or invasive infections beyond the external canal.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and children, the typical dosage involves instilling 4 drops of the solution into the affected ear canal 3 to 4 times daily. For optimal absorption and contact with the ear canal tissues, the patient should lie with the affected ear upward, and the drops should be administered carefully. The position should be maintained for at least 5 minutes after instillation to allow the medication to penetrate effectively. Alternatively, a cotton wick may be inserted into the ear canal and saturated with the solution, keeping it moist by adding 3 to 4 drops every four hours. The wick should be replaced at least once every 24 hours. The duration of treatment typically ranges from 7 to 10 days, depending on the severity of the infection and clinical response, but should not exceed 10 consecutive days without re-evaluation by a healthcare professional due to the potential for adverse effects, particularly ototoxicity and superinfection. |
Safety & Warnings
Common Side Effects
- Commonly reported side effects associated with polymyxin B + neomycin + hydrocortisone otic solution are primarily local and include transient stinging or burning sensations upon instillation, itching, and irritation within the ear canal.
- Hypersensitivity reactions, particularly to neomycin, are a significant concern and can manifest as local redness, scaling, itching, and swelling, which may sometimes mimic a worsening of the underlying infection.
- Prolonged use or use in the presence of a perforated tympanic membrane carries a serious risk of ototoxicity, leading to permanent hearing loss or vestibular damage.
- Other potential, though rare, side effects include superinfection with non-susceptible bacteria or fungi, especially with prolonged use of corticosteroids or antibiotics.
- Systemic absorption leading to adrenal suppression is highly unlikely with topical otic use but theoretically possible with very long-term or extensive application, particularly in children or with occlusive conditions.
Serious Warnings
- Black Box Warning: While a formal FDA Black Box Warning has not been issued for otic formulations of polymyxin B + neomycin + hydrocortisone, severe safety concerns necessitate prominent warnings. The most critical risk is **Ototoxicity**, specifically irreversible sensorineural hearing loss and vestibular damage, associated with the neomycin component. This risk is profoundly increased if the tympanic membrane (eardrum) is perforated, allowing direct passage of neomycin to the inner ear. Therefore, this product is **absolutely contraindicated in patients with a perforated tympanic membrane**, and a thorough otoscopic examination to confirm an intact tympanic membrane is mandatory prior to administration. Furthermore, **hypersensitivity reactions**, particularly to neomycin, are common and can range from local irritation to severe allergic contact dermatitis, sometimes mimicking an exacerbation of the condition being treated. Discontinue use immediately if signs of hypersensitivity appear. Prolonged use can lead to **superinfection** by non-susceptible organisms, including fungi, and the corticosteroid can mask signs of these infections. Patients should be monitored for new or worsening symptoms that may indicate these severe adverse effects, and treatment duration should not exceed the recommended period without re-evaluation by a healthcare professional.
- This medication should be used with extreme caution.
- The most critical warning pertains to ototoxicity: neomycin, an aminoglycoside antibiotic component, can cause irreversible sensorineural hearing loss and vestibular damage.
- This risk is significantly elevated if the tympanic membrane is perforated, as the medication can directly access the inner ear.
- Therefore, a thorough otoscopic examination to rule out tympanic membrane perforation is mandatory before initiating treatment.
- Prolonged use of corticosteroid-containing preparations may lead to superinfection by non-susceptible bacteria, fungi, or viruses, and the corticosteroid can mask the clinical signs of these infections.
- Patients should be advised to discontinue treatment and consult a physician if ear discharge persists, becomes purulent, or if irritation or new symptoms develop, which could indicate a hypersensitivity reaction, particularly to neomycin, or a superinfection.
- Cross-sensitization to other aminoglycoside antibiotics may occur.
- Avoid contact with the eyes.
- If symptoms do not improve within 7-10 days, the diagnosis should be re-evaluated to rule out resistant organisms or other etiologies.
How it Works (Mechanism of Action)
The therapeutic efficacy of polymyxin B + neomycin + hydrocortisone stems from the synergistic actions of its three active components. Polymyxin B, a polypeptide antibiotic, primarily acts by disrupting the integrity of the bacterial cell membrane in Gram-negative bacteria (e.g., Pseudomonas aeruginosa), leading to leakage of intracellular components and subsequent cell death. Neomycin, an aminoglycoside antibiotic, binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting bacterial protein synthesis and causing errors in genetic code translation, resulting in a bactericidal effect against a broad spectrum of Gram-positive (e.g., Staphylococcus aureus) and Gram-negative organisms. Hydrocortisone, a potent corticosteroid, exerts its therapeutic effects by inhibiting the release of arachidonic acid from phospholipids via the enzyme phospholipase A2, thereby suppressing the formation of inflammatory mediators such as prostaglandins and leukotrienes. This action provides anti-inflammatory, antipruritic, and vasoconstrictive properties, effectively reducing redness, swelling, and itching associated with otitis externa, and alleviating discomfort for the patient.
Commercial Brands (Alternatives)
No other brands found for this formula.